Alumis is advancing ESK-001 for plaque psoriasis with phase 3 data expected in 2026. Read why ALMS stock is compelling yet ...

Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today ...

Goldman Sachs reports that retailers are allocating the most incremental space on the backbar this year to oral nicotine ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

Once a controversial European depression treatment that never made it to the U.S. | The treatment, which was once a Pfizer ...

Verona's approval of ensifentrine in COPD offers promising potential with its MoA and safety profile in a competitive market.

The biotech industry has been described as the Wild West of the stock market. Although some companies manage to develop and ...

Investors are assessing the likelihood Trump will deliver on his threat to impose fresh tariffs on China, Canada and Mexico.

Raw milk has surged in popularity across Florida and the rest of the country over the last few years, a trend in part driven ...

An app-based courier service says their delivery drivers have been run off their feet since Canada Post workers went on ...

Eli Lilly reported total tirzepatide sales that rocketed 272% year over year to $11 billion during the first nine months of ...